TSH Biopharm (ROCO:8432) ROE % Adjusted to Book Value : 8.85% (As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is TSH Biopharm ROE % Adjusted to Book Value?

TSH Biopharm's ROE % for the quarter that ended in Sep. 2024 was 14.33%. TSH Biopharm's PB Ratio for the quarter that ended in Sep. 2024 was 1.62. TSH Biopharm's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 8.85%.

TSH Biopharm ROE % Adjusted to Book Value Historical Data

The historical data trend for TSH Biopharm's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TSH Biopharm ROE % Adjusted to Book Value Chart

TSH Biopharm Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

2.84

2.72

2.70

3.47

3.18

TSH Biopharm Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															3.87	3.40	7.94	2.12	8.85

Competitive Comparison of TSH Biopharm's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, TSH Biopharm's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TSH Biopharm's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TSH Biopharm's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where TSH Biopharm's ROE % Adjusted to Book Value falls into.

TSH Biopharm ROE % Adjusted to Book Value Calculation

TSH Biopharm's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	5.53%	/	1.74
	=	3.18%

TSH Biopharm's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	14.33%	/	1.62
	=	8.85%

TSH Biopharm ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of TSH Biopharm's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

TSH Biopharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TSH Biopharm Corp Ltd (ROCO:8432) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.3-1, Park Street, 3rd Floor-1, Nangang District, Taipei, TWN, 115

Website

https://www.tshbiopharm.com

TSH Biopharm Corp Ltd is engaged in the sale of a variety of pharmaceuticals, chemical drugs and biotechnology services. The Company's revenue is earned domestically. It earns majority of its revenue from the sale of Lozenges.

TSH Biopharm Headlines

No Headlines